Back to Alerts
$MVO
WATCHING
65
Score
$0.84
Price
+6.0%
Change
1.8x
Volume
📊 Score Breakdown
Options Activity
20/35
News Catalyst
25/25
Social Buzz
8/20
Price Confirmation
12/20
📊 Options Activity
Unusual Activity Detected
IV Spike
📰 News (10 articles)
Viridian Therapeutics' Lumvoa Could Start Generating More Meaningful Revenue in 2027, RBC Says
Viridian Therapeutics Announces U.S. FDA Approval and Launch of Lumvoa veligrotug-vvze for the Treat
DRI Healthcare Comments on Viridian's FDA Approval and Launch of Lumvoa veligrotug-vvze
💬 Social Buzz
Social Sentiment: 86% Bullish